The U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS
The U.S. Department of State, Gilead Sciences, and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the launch of a large-scale initiative to expand access to lenacapavir — the first injectable HIV prevention medication administered twice a year. The announcement was made at an official U.S. State Department briefing, held in the […]